Kymera Therapeutics, Inc. (KYMR)
121.05
+1.25
(+1.04%)
USD |
NASDAQ |
Aug 24, 16:00
121.01
-0.04
(-0.03%)
After-Hours: 20:00
Kymera Therapeutics Price : 121.05 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 119.98 | 121.56 | 116.46 | 121.05 | 466859.0 |
| Aug 21, 2026 | 122.87 | 125.71 | 119.77 | 119.80 | 503430.0 |
| Aug 20, 2026 | 124.95 | 125.45 | 121.13 | 121.50 | 580746.0 |
| Aug 19, 2026 | 124.63 | 127.36 | 121.82 | 127.31 | 842927.0 |
| Aug 18, 2026 | 119.75 | 122.14 | 118.09 | 121.38 | 640892.0 |
| Aug 17, 2026 | 117.39 | 122.59 | 117.04 | 121.41 | 704715.0 |
| Aug 14, 2026 | 112.90 | 118.04 | 110.05 | 117.39 | 468580.0 |
| Aug 13, 2026 | 114.73 | 114.73 | 112.44 | 114.42 | 481718.0 |
| Aug 12, 2026 | 110.22 | 115.00 | 109.08 | 114.03 | 961008.0 |
| Aug 11, 2026 | 108.79 | 110.37 | 106.30 | 109.62 | 2.380M |
| Aug 10, 2026 | 106.63 | 109.05 | 106.04 | 108.58 | 404887.0 |
| Aug 07, 2026 | 106.61 | 108.12 | 104.78 | 107.52 | 463575.0 |
| Aug 06, 2026 | 105.00 | 107.04 | 103.37 | 106.41 | 510919.0 |
| Aug 05, 2026 | 104.86 | 107.90 | 103.84 | 105.48 | 586318.0 |
| Aug 04, 2026 | 101.75 | 104.95 | 100.53 | 104.39 | 601565.0 |
| Aug 03, 2026 | 102.77 | 103.00 | 99.52 | 100.31 | 666797.0 |
| Jul 31, 2026 | 106.25 | 106.72 | 102.13 | 103.40 | 511843.0 |
| Jul 30, 2026 | 105.66 | 107.82 | 104.32 | 107.01 | 444448.0 |
| Jul 29, 2026 | 105.00 | 108.28 | 104.12 | 105.25 | 505615.0 |
| Jul 28, 2026 | 108.78 | 110.36 | 105.45 | 106.16 | 679867.0 |
| Jul 27, 2026 | 110.57 | 113.00 | 109.92 | 110.05 | 474166.0 |
| Jul 24, 2026 | 114.14 | 114.14 | 108.31 | 110.57 | 585217.0 |
| Jul 23, 2026 | 109.06 | 112.33 | 107.40 | 110.38 | 431638.0 |
| Jul 22, 2026 | 110.92 | 113.63 | 110.18 | 110.34 | 538337.0 |
| Jul 21, 2026 | 110.25 | 113.83 | 110.25 | 113.37 | 565378.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Oncolytics Biotech, Inc. | 0.8441 |
| Sangamo Therapeutics, Inc. | 0.16 |
| Sarepta Therapeutics, Inc. | 18.13 |
| Anixa Biosciences, Inc. | 3.62 |
Price Related Metrics
| PS Ratio | 107.48 |
| Price to Book Value | 6.64 |
| Earnings Yield | -2.68% |
| Market Cap | 10.02B |